Stellus Capital Investment Corp - Form 8-K Summary
Business Context and Reporting Period
Stellus Capital Investment Corporation (SCM), a Maryland corporation, filed this Current Report on Form 8-K on September 10, 2025, regarding an event that occurred on September 9, 2025. The company is registered on the New York Stock Exchange under the symbol SCM.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, or specific debt levels. The report focuses exclusively on a new financing arrangement.
Material Changes
On September 9, 2025, the Company entered into an Equity Distribution Agreement with Keefe, Bruyette & Woods, Inc. and Raymond James & Associates, Inc. as sales agents. Key terms include:
- Offering Size: The Company may issue and sell up to $100,000,000 in aggregate offering price of its common stock.
- Method: Sales will be conducted via an "at-the-market" offering at prevailing market prices.
- Compensation: Sales agents will receive a commission of 1.5% of the gross sales price of shares sold.
- Use of Proceeds: Net proceeds are intended to repay certain outstanding indebtedness and fund investments in portfolio companies.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance or outlook metrics. Management commentary is limited to the strategic intent of using proceeds for debt repayment and portfolio investments. The agreement includes customary representations, warranties, indemnification rights, and termination provisions. The filing explicitly states it does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the current outstanding indebtedness levels to assess the impact of the intended debt repayment.
- Review the full text of the Equity Distribution Agreement (Exhibit 10.1) for specific termination rights and conditions.
- Monitor future filings for actual share issuance volumes and proceeds raised under the $100 million cap.
- Check the Prospectus Supplement dated September 9, 2025, for detailed risk factors associated with the offering.